Scott B. Ullem sold $797k of EW
CVP, Chief Financial Officer at Edwards Lifesciences Corp. 11,250 shares at an average of $70.87, traded Mar 26, 2025, filed Mar 26, 2025.
Score components
- +22RoleCFO
- +22Trade size$797k at market
- +10Share of holdings soldSold 27% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-003654, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | MOption exercise Common Stock10b5-1 | +11,250 | $45.28 | $509k | 41,637 | Mar 26, 2025 |
| Mar 26, 2025 | SOpen-market sale Common Stock10b5-1 | -11,250 | $70.87 | $797k | 30,387 | Mar 26, 2025 |
| Mar 26, 2025 | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,250 | $0.00 | $0 | 11,250 | Mar 26, 2025 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k | 619 | |
| 20Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $646k | 9,500 | |
| 0Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, JAPAC | $28k | 400 | |
| 22Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Bernard J Zovighian CEO | $428k | 6,164 | |
| 34Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $796k | 11,250 | |
| 32Weak | sell 5 | EW Edwards Lifesciences Corp | Steven R Loranger director | $439k | 5,739 | |
| 18Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $492k | 6,500 | |
| 37Weak | sell 5 | EW Edwards Lifesciences Corp | Heisz Leslie Stone director | $435k | 5,739 | |
| 1Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, JAPAC | $38k | 500 | |
| 35Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $852k | 11,250 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.